创模生物科技(北京)有限公司

CN / En

NEWS

Analysis of the Features ofInnoModels’ADCC Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-08-01 16:29
  • Views:

(Summary description)In the field of biomedicine, antibody-dependent cell-mediated cytotoxicity (ADCC), as a key mechanism in tumor immunotherapy, has always attracted the attention of many researchers. In order to meet the growing research needs, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully built an in vitro pharmacodynamics platform, among which the ADCC platform has won wide recognition in the industry with its unique features and advantages. This article will introduce in detail several major features of InnoModels' ADCC platform.

Analysis of the Features ofInnoModels’ADCC Platform

(Summary description)In the field of biomedicine, antibody-dependent cell-mediated cytotoxicity (ADCC), as a key mechanism in tumor immunotherapy, has always attracted the attention of many researchers. In order to meet the growing research needs, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully built an in vitro pharmacodynamics platform, among which the ADCC platform has won wide recognition in the industry with its unique features and advantages. This article will introduce in detail several major features of InnoModels' ADCC platform.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-08-01 16:29
  • Views:
Information

In the field of biomedicine, antibody-dependent cell-mediated cytotoxicity (ADCC), as a key mechanism in tumor immunotherapy, has always attracted the attention of many researchers. In order to meet the growing research needs, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully built an in vitro pharmacodynamics platform, among which the ADCC platform has won wide recognition in the industry with its unique features and advantages. This article will introduce in detail several major features of InnoModels' ADCC platform.
Diversified experimental service system
InnoModels' ADCC platform is first known for its diversified experimental service system. The platform can support combinatorial experiments on multiple types of tumor cells and immune cells. Whether it is tumor cell lines, primary tumor cells or genetically engineered cell lines, the platform can provide corresponding experimental conditions and technical support. This diversity not only meets the needs of different research projects, but also provides researchers with a wealth of options to choose the most appropriate cell type according to specific research goals.
In terms of effector cells, the platform also supports commercially derived PBMC (peripheral blood mononuclear cells) and clinical patient-derived PBMC. This support allows researchers to get closer to clinical reality and more accurately simulate the immune response process in the human body, thus improving the reliability and practicality of research.
Real simulation environment
In order to more truly reflect the actual situation of the ADCC process, InnoModels Bio's ADCC platform focuses on simulating the in vivo environment. The platform uses advanced cell culture technology and flow cytometry technology to monitor and record changes in cells during the experiment in real time. This technical method not only improves the accuracy of experiments, but also provides researchers with accurate and reliable data support, helping them to understand the details of the ADCC mechanism more deeply.

 


Highly customizable
InnoModels' ADCC platform is also highly customizable. The platform can customize personalized experimental plans according to the specific needs of researchers, including cell type, drug treatment, experimental time and other aspects. This flexibility enables the platform to meet the diverse needs of different researchers and provides powerful technical support for biomedical research. At the same time, it also avoids the "one size fits all" experimental model and improves the pertinence and efficiency of the research.
Efficient data processing capabilities
In addition to its advantages in experimental design and execution, InnoModels' ADCC platform is also equipped with an advanced data analysis system. This system can automatically process and analyze experimental data, greatly improving the efficiency and accuracy of data processing. Researchers can intuitively understand experimental results through the visual reports provided by the platform, thereby better guiding subsequent research work. This efficient data processing capability not only saves researchers time and energy, but also improves the overall quality and level of research.
Leading technological breakthroughs
InnoModels' innovation in the biomedical field is not only reflected in the ADCC platform, but also includes a series of other leading technological breakthroughs.For example, the company's iHuPDX in vivo drug efficacy model technology, based on xenograft technology of individual patient tumor cells, provides strong support for precision medicine. In addition, InnoModels Biotechnology has also successfully optimized a humanized mouse model of the PBMC immune system, achieving NK reconstruction close to clinical levels, providing a more reliable model for preclinical efficacy verification of NK-related immunotherapy drugs.
Conclusion
To sum up, InnoModels' ADCC platform plays an important role in biomedical research with its diversified experimental service system, realistic simulation environment, high degree of customizability, and efficient data processing capabilities. In the future, as the biomedical field continues to develop, InnoModels' ADCC platform will continue to leverage its unique advantages to promote the progress and innovation of biomedical research. At the same time, the company will continue to be committed to innovation and development in the biomedical field to bring good news to more patients.

Keyword:

With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
Previous page
1
2
42
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司